Small scale IHC analysis using different stages of CRAC samples suggest a trend of MET and/or RON expression increasing from normal to adenoma to adenocarcinoma, and finally to metastatic lesions [25, 44, 45]. The gene discussed is MST1R; the disease is adenoma.